Clinical Trials · NCT06914141
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 28,118
- Start date
- Jan 2025
- Locations
- 1 site, United States
- Primary endpoint
- Composite of all-cause mortality or heart failure hospitalization